Skip to main content

Skin Cancer Specialty Channel

Featured Article
Which of the following as adjuvant therapy results in significantly longer recurrence-free survival compared with placebo for high-risk stage III…
Pembrolizumab as adjuvant therapy results in significantly longer recurrence-free survival compared with placebo for high-risk stage III melanoma.
Test your knowledge on the latest research in melanoma therapy and treatment.
Expert Insights
Expert-reviewed information summary about the treatment of melanoma.
Expert-reviewed information summary about the genetics of skin cancer — basal cell carcinoma, squamous cell carcinoma, and melanoma — including…
Expert-reviewed information summary about tests used to detect or screen for skin cancer.
Expert-reviewed information summary about the treatment of skin cancer.
Interactive Features
Which of the following as adjuvant therapy results in significantly longer recurrence-free survival compared with placebo for high-risk stage III…
Test your knowledge on the latest research in melanoma therapy and treatment.

According to a recent study published in JAMA Dermatology, which of the following factors do NOT contribute to treatment delay in…